Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The primary objective of the study is to check if an subcutaneous (sc) infusion of UCB7665 is safe and tolerated in subjects with primary immune thrombocytopenia.
Epistemonikos ID: eeafe99f2ff5676d904e7a87f5f0aadc07abe675
First added on: May 12, 2024